Extraordinary General Meeting of shareholders
May 28, 2019
Kiadis Pharma N.V. has convened an extraordinary general meeting of shareholders (“EGM”) to obtain shareholder approval pursuant to section 2:107a of the Dutch Civil Code for the proposed acquisition of CytoSen Therapeutics, Inc. that was announced earlier today. The EGM is to be held on Wednesday, May 29, 2019 at 10:00am CEST at the Amsterdam Stock Exchange (Euronext), Beursplein 5, 1012 JW Amsterdam, The Netherlands. On the registration date (registratiedatum) for the EGM, Kiadis Pharma N.V. had 24,345,076 shares issued, each representing one vote.
Amsterdam, The Netherlands